QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:QDEL • US2197981051

28.12 USD
-0.98 (-3.37%)
Last: Feb 9, 2026, 11:33 AM
Fundamental Rating

3

Overall QDEL gets a fundamental rating of 3 out of 10. We evaluated QDEL against 186 industry peers in the Health Care Equipment & Supplies industry. QDEL may be in some trouble as it scores bad on both profitability and health. QDEL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year QDEL was profitable.
  • QDEL had a positive operating cash flow in the past year.
  • In multiple years QDEL reported negative net income over the last 5 years.
  • QDEL had a positive operating cash flow in each of the past 5 years.
QDEL Yearly Net Income VS EBIT VS OCF VS FCFQDEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

  • QDEL has a Return On Assets (-20.78%) which is in line with its industry peers.
  • QDEL has a Return On Equity of -57.90%. This is comparable to the rest of the industry: QDEL outperforms 48.39% of its industry peers.
  • QDEL's Return On Invested Capital of 1.74% is fine compared to the rest of the industry. QDEL outperforms 67.74% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for QDEL is below the industry average of 8.80%.
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROIC 1.74%
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
QDEL Yearly ROA, ROE, ROICQDEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • With a decent Operating Margin value of 3.98%, QDEL is doing good in the industry, outperforming 68.28% of the companies in the same industry.
  • In the last couple of years the Operating Margin of QDEL has declined.
  • QDEL has a Gross Margin (47.15%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 47.15%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
QDEL Yearly Profit, Operating, Gross MarginsQDEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
  • The number of shares outstanding for QDEL has been increased compared to 1 year ago.
  • Compared to 5 years ago, QDEL has more shares outstanding
  • Compared to 1 year ago, QDEL has a worse debt to assets ratio.
QDEL Yearly Shares OutstandingQDEL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
QDEL Yearly Total Debt VS Total AssetsQDEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.78, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
  • QDEL has a Altman-Z score (0.78) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.23 is on the high side and indicates that QDEL has dependencies on debt financing.
  • QDEL's Debt to Equity ratio of 1.23 is on the low side compared to the rest of the industry. QDEL is outperformed by 76.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACC0.17
WACC9.97%
QDEL Yearly LT Debt VS Equity VS FCFQDEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that QDEL should not have too much problems paying its short term obligations.
  • QDEL's Current ratio of 1.78 is on the low side compared to the rest of the industry. QDEL is outperformed by 66.13% of its industry peers.
  • QDEL has a Quick Ratio of 1.78. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of QDEL (0.98) is worse than 74.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.98
QDEL Yearly Current Assets VS Current LiabilitesQDEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

  • QDEL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.18%.
  • Measured over the past years, QDEL shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.03% on average per year.
  • Looking at the last year, QDEL shows a decrease in Revenue. The Revenue has decreased by -3.67% in the last year.
  • Measured over the past years, QDEL shows a very strong growth in Revenue. The Revenue has been growing by 39.07% on average per year.
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%

3.2 Future

  • QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.56% yearly.
  • The Revenue is expected to grow by 1.98% on average over the next years.
EPS Next Y14.64%
EPS Next 2Y17.58%
EPS Next 3Y21.87%
EPS Next 5Y21.56%
Revenue Next Year-2.44%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.3%
Revenue Next 5Y1.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
QDEL Yearly Revenue VS EstimatesQDEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
QDEL Yearly EPS VS EstimatesQDEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

  • QDEL is valuated correctly with a Price/Earnings ratio of 12.28.
  • 92.47% of the companies in the same industry are more expensive than QDEL, based on the Price/Earnings ratio.
  • QDEL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.93.
  • QDEL is valuated reasonably with a Price/Forward Earnings ratio of 10.99.
  • QDEL's Price/Forward Earnings ratio is rather cheap when compared to the industry. QDEL is cheaper than 93.55% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of QDEL to the average of the S&P500 Index (27.77), we can say QDEL is valued rather cheaply.
Industry RankSector Rank
PE 12.28
Fwd PE 10.99
QDEL Price Earnings VS Forward Price EarningsQDEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 95.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.3
QDEL Per share dataQDEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • QDEL's earnings are expected to grow with 21.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y17.58%
EPS Next 3Y21.87%

0

5. Dividend

5.1 Amount

  • QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

QUIDELORTHO CORP

NASDAQ:QDEL (2/9/2026, 11:33:03 AM)

28.12

-0.98 (-3.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-11
Inst Owners123.47%
Inst Owner Change-1.26%
Ins Owners0.61%
Ins Owner Change1.31%
Market Cap1.91B
Revenue(TTM)2.71B
Net Income(TTM)-1.18B
Analysts74.29
Price Target38.18 (35.78%)
Short Float %15.76%
Short Ratio10.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)381.21%
Min EPS beat(2)70.71%
Max EPS beat(2)691.7%
EPS beat(4)4
Avg EPS beat(4)197.7%
Min EPS beat(4)4.59%
Max EPS beat(4)691.7%
EPS beat(8)7
Avg EPS beat(8)123.74%
EPS beat(12)10
Avg EPS beat(12)89.01%
EPS beat(16)13
Avg EPS beat(16)77.39%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.19%
Revenue beat(4)1
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)8
Avg Revenue beat(12)2.03%
Revenue beat(16)11
Avg Revenue beat(16)2.72%
PT rev (1m)1.55%
PT rev (3m)-6.82%
EPS NQ rev (1m)-20.43%
EPS NQ rev (3m)-53.46%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-6.44%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 12.28
Fwd PE 10.99
P/S 0.7
P/FCF N/A
P/OCF 51.21
P/B 0.94
P/tB N/A
EV/EBITDA 8.3
EPS(TTM)2.29
EY8.14%
EPS(NY)2.56
Fwd EY9.1%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)0.55
OCFY1.95%
SpS39.96
BVpS29.98
TBVpS-8.41
PEG (NY)0.84
PEG (5Y)N/A
Graham Number39.3
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -57.9%
ROCE 2.2%
ROIC 1.74%
ROICexc 1.78%
ROICexgc 3.88%
OM 3.98%
PM (TTM) N/A
GM 47.15%
FCFM N/A
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexgc growth 3Y-72.1%
ROICexgc growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF N/A
Debt/EBITDA 4.57
Cap/Depr 43.31%
Cap/Sales 7%
Interest Coverage 250
Cash Conversion 6.82%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.98
Altman-Z 0.78
F-Score5
WACC9.97%
ROIC/WACC0.17
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.18%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-5.88%
EPS Next Y14.64%
EPS Next 2Y17.58%
EPS Next 3Y21.87%
EPS Next 5Y21.56%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-3.74%
Revenue Next Year-2.44%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.3%
Revenue Next 5Y1.98%
EBIT growth 1Y4.34%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year937.85%
EBIT Next 3Y132.29%
EBIT Next 5Y90.11%
FCF growth 1Y-203.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.9%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%

QUIDELORTHO CORP / QDEL FAQ

Can you provide the ChartMill fundamental rating for QUIDELORTHO CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QDEL.


What is the valuation status for QDEL stock?

ChartMill assigns a valuation rating of 6 / 10 to QUIDELORTHO CORP (QDEL). This can be considered as Fairly Valued.


What is the profitability of QDEL stock?

QUIDELORTHO CORP (QDEL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of QUIDELORTHO CORP (QDEL) stock?

The Price/Earnings (PE) ratio for QUIDELORTHO CORP (QDEL) is 12.28 and the Price/Book (PB) ratio is 0.94.


Can you provide the expected EPS growth for QDEL stock?

The Earnings per Share (EPS) of QUIDELORTHO CORP (QDEL) is expected to grow by 14.64% in the next year.